Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow aspirate versus concentrated bone marrow aspirate versus triamcinolone for hip osteoarthritis
RBR-3yxrgtzPhase 2Not yet recruiting
- Sponsor
- Fundação Arnaldo Vieira de Carvalho
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of autologous bone marrow aspirate, autologous bone marrow cell concentrate, triamcinolone and lidocaine in hip osteoarthritis (3 arms), sponsored by Fundação Arnaldo Vieira de Carvalho. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
autologous bone marrow aspirateautologous bone marrow cell concentratetriamcinolonelidocaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on RBR-3yxrgtz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3yxrgtz.